Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from HeLa cells treated with Casiopeina Cas-II-gly


ABSTRACT: Copper-based chemotherapeutic compounds Casiopeinas, have been presented as able to promote selective programmed cell death in cancer cells, thus being proper candidates for targeted cancer therapy. DNA fragmentation and apoptosis -in a process mediated by reactive oxygen species- for a number of tumor cells, have been argued to be the main mechanisms. However, a detailed functional mechanism (a model) is still to be defined and interrogated for a wide variety of cellular conditions; before establishing settings and parameters needed for their wide clinical application. Microarrays were used to determine the expression profile from HeLa cells in order to propose a model for the role played by intrinsic apoptosis triggered by the oxidative stress caused by Cas-II-gly. The cervix-uterine cell line HeLa  was maintained at 37C in 5% CO2  under sterile conditions in Dulbecco's modified Eagle medium (DMEM, Sigma), supplemented with 10% fetal bovine serum (Sigma). Cells were treated with Cas II-gly in 96-well microplates by 6 h.  HeLa cells whole genome gene expression experiments (triplicates for cases/controls) were performed in total mRNA extracted under the GPL570 protocol.

ORGANISM(S): Homo sapiens

SUBMITTER: Karol Baca Lopez 

PROVIDER: E-GEOD-41827 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications


Copper-based chemotherapeutic compounds Casiopeínas, have been presented as able to promote selective programmed cell death in cancer cells, thus being proper candidates for targeted cancer therapy. DNA fragmentation and apoptosis-in a process mediated by reactive oxygen species-for a number of tumor cells, have been argued to be the main mechanisms. However, a detailed functional mechanism (a model) is still to be defined and interrogated for a wide variety of cellular conditions before establi  ...[more]

Similar Datasets

2012-10-31 | GSE41827 | GEO
2025-01-24 | E-GEOD-41827 | ExpressionAtlas
| PRJNA178551 | ENA
2014-02-22 | E-GEOD-55241 | biostudies-arrayexpress
| FBgn0004878 | ExpressionAtlas
| FBgn0004878 | ExpressionAtlas
| AT2G46520 | ExpressionAtlas
| AT2G46520 | ExpressionAtlas
2025-01-24 | E-GEOD-53280 | ExpressionAtlas
| PRJNA445659 | ENA